Performance of a Point-of-Care Fluorescence Immunoassay Test to Measure the Anti-Severe Acute Respiratory Syndrome Corona Virus 2 Spike, Receptor Binding Domain Antibody Level

Performance of a Point-of-Care Fluorescence Immunoassay Test to Measure the Anti-Severe Acute Respiratory Syndrome Corona Virus 2 Spike, Receptor Binding Domain Antibody Level

Quantitative determination of anti-SARS-CoV2-S-RBD is necessary for the evaluation of vaccination effectiveness. The surrogate viral neutralization test (SVNT) is approved for measuring anti-SARS-CoV2-S-RBD, but a point-of-care platform is needed to simplify anti-SARS-CoV-2-S-RBD measurement. We aim...

Full description

Bibliographic Details
Main Authors: Marita Restie Tiara, Hofiya Djauhari, Febi Ramdhani Rachman, Antonius Christianus Rettob, Darmastuti Utami, Fahda Cintia Suci Pulungan, Heru Purwanta, Rudi Wisaksana, Bachti Alisjahbana, Agnes Rengga Indrati
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Diagnostics
Subjects:
COVID-19
vaccination
antibody
immunoassay
Online Access:https://www.mdpi.com/2075-4418/13/24/3686

Similar Items

Similar Items